Alkaloid extracts of four Amaryllidaceae species were studied with respect to their acetylcholinesterase and butyrylcholinesterase inhibitory activity and alkaloid patterns. Twenty-one alkaloids were determined by GC/MS, and seventeen of them identified from their mass spectra and retention times. The GC/MS analysis of the alkaloid extract of Nerine filamentosa is the first phytochemical investigation of this species. Promising erythrocytic acetylcholinesterase inhibitory activity was demonstrated by the alkaloid extracts of Narcissus poeticus var recurvus, Nerine filifolia and N. filamentosa (IC 50,HuAChE = 6.0 ± 0.1 µg/mL; IC 50,HuAChE = 18.5 ± 0.8 µg/mL, IC 50,HuAChE = 21.6 ± 1.1 µg/mL). The most potent inhibitory activity against serum butyrylcholinesterase was shown by extracts of Sternbergia lutea and Nerine filamentosa (IC 50,HuBuChE = 3.7 ± 0.1 µg/mL; IC 50,HuBuChE = 13.0 ± 0.7 µg/mL).
Neurodegenerative disorders are characterized by progressive and irreversible loss of neurons from specific regions of the brain. Alzheimer´s disease (AD) is the most predominant cause of dementia in the elderly, affecting more than 20 million people worldwide and it is estimated that this figure will increase to 114 million by 2040 [1] . AD is the fourth leading cause of death for people over 65 years in Western industrial countries and is becoming more and more common. In other words, increased life expectancy is directly related to the increasing number of elderly people and consequently proportional to the rising number of senile disorders, including neurodegenerative diseases. The etiology of AD is still unknown, but postmortem studies have shown two characteristic pathologic hallmarks, senile plaques (SPs) and neurofibrillary tangles (NFTs). SPs are an extracellular accumulation of beta-amyloid (Aß) surrounded by dystrophic neurites and microglia. Aß originates from the proteolysis of the amyloid precursor protein (APP) through sequential cleavage by beta-site amyloid precursor protein-cleaving enzyme 1(BACE-1, ßsecretase) and γ-secretase [2] . In AD patients, deficit of the neurotransmitter acetylcholine (ACh) in the cortex results in a deterioration of the level of cholinergic functions, and this is responsible for the memory impairments [3] . The principal role of acetylcholinesterase (AChE) is the termination of nerve impulse transmission at the cholinergic synapses by rapid hydrolysis of acetylcholine (ACh). Currently, acetylcholinesterase inhibition is the most used therapeutic approach in treatment of AD symptoms [4] . However, not only AChE participates in the cholinergic regulation of the central nervous system (CNS) in humans, but also another enzyme, butyrylcholinesterase (BuChE), which is able to hydrolyze Ach, as well as other ester compounds [5] . BuChE is associated with the NFTs and SPs and its activity increases in the AD brain, where it is co-localized with Aß fibrils [6] . In severe AD, levels of AChE and choline acetyltransferase are decreased by as much as 90% compared with a normal state, while the concentration of BuChE increases [7] . This fact has targeted BuChE as a new approach to affect the progression of AD. Therefore, research into new inhibitors with dual enzymatic activity is required.
The history of drug discovery has shown that plants are a rich source of new bioactive compounds. Plants of various families (for example, Papaveraceae, Fumariaceae, and Amaryllidaceae) [8] have been used in the treatment of memory dysfunctions in some folk medicines for centuries.
Amaryllidaceae species are known as ornamental plants and produce structurally unique alkaloids with a wide range of interesting physiological effects, for example, antitumor, antiviral, cholinesterase inhibitory, immune stimulatory and antimalarial [9] [10] [11] . A wide range of Amaryllidaceae species has been extensively used in traditional medicine to treat a variety of health problems. Some species of this family contain galanthamine, a long acting, selective, reversible and competitive acetylcholinesterase (AChE) inhibitor approved for the treatment of Alzheimer´s disease [8] . The search for more potent and effective AChE inhibitors from natural sources has led to the isolation of other Amaryllidaceae alkaloids, such as sanguinine, habranthine and 1-O-acetyllycorine, which possess either similar or stronger activity than galanthamine [10] .
The present work represents a continuation of our previous studies [12] [13] [14] [15] , which dealt with searching Amaryllidaceae plants for interesting AChE and BuChE inhibition activity. Herein we report the GC/MS analysis of the alkaloid extracts from the bulbs of Nerine filifolia Baker, N. filamentosa W. F. Barker, Narcissus poeticus var. recurvus (Haw) Baker, and Sternbergia lutea (L.) Ker Gawl. ex Spreng. The inhibitory effect of these extracts on the activity of human erythrocytic AChE (HuAChE) and plasma BuChE (HuBuChE) was investigated as well. The GC/MS analysis of the alkaloid extract of bulbs of N. filamentosa is the first chemical investigation of this species.
In the bulb extracts of the studied species, twenty-one alkaloids of the crinine, haemanthamine, galanthamine and homolycorine type were detected by GC/MS, seventeen of which were identified based on their retention times and mass spectra ( Table 1 ). The relative proportion of each alkaloid was determined as a percentage of the total ion current (TIC). The peak areas reflect the ability of each compound to ionize and thus the data given in the Table 1 are semiquantitative. Nevertheless, they can be used for comparison between samples.
The genus Nerine, the second largest within the Amaryllidaceae with ca 30 species, is an autumn-flowering perennial bulbous plant group, whose species inhabit areas with summer rainfall and cold, dry winters [16] . Previous phytochemical investigations of N. filifolia led to the isolation and identification of eight alkaloids, with belladine, 11-O-acetylambelline and undulatine as major constituents [17] . In our study of the alkaloid profile of N. filifolia, seven compounds showed MS fragmentation patterns characteristic of the Amaryllidaceae alkaloids, and six of them were identified. The alkaloid pattern of the bulbs was dominated by homolycorinetype alkaloids, which showed a base ion at m/z 109, indicating that there is no substitution at C-2, and lesser fragments at m/z 162 and 190, suggesting a lactone moiety with a methylenedioxy group at C-8/C-9. The MS was congruent with those reported by Kreh et al. [18] and Berkov et al. [19] , and with that of masonine (14) in the MS library NIST 08. The next major components were identified as N-demethylmasonine (18, 11% of TIC), which is an Ndemethylated alkaloid of the lycorenine type, and the crinine-type alkaloid caranine (6, 9% of TIC). Both spectra were available in either the literature or the NIST library [18] . Masonine and Ndemethylmasonine were already found by GC/MS in Galanthus elwesii [19] , and isolated from some Narcissus species [20] [21] .
The alkaloid pattern of N. filamentosa was dominated by three crinine-type alkaloids: undulatine (16; 42% of TIC), buphanamine (10; 20% of TIC), and ambelline (17; 13% of TIC), and one lycorine-type alkaloid, tentatively identified as acetylparkamine (19; 11% of TIC). Parkamine (20) and acetylparkamine (19) were identified by comparing their MS with those of known compounds of the same structural type (caranine, acetylcaranine, falcatine and acetylfalcatine), which are available in the NIST library. Compound 20 (parkamine) showed a spectrum typical of a lycorine-type alkaloid substituted at either C-1, or C-1 and C-2 [22] . This compound revealed the same type of fragmentation pattern as caranine and falcatine. All the compounds have an intense molecular ion [M + ] and a less abundant [M-1] + ion, from which substituents at C-1 or C-2 were eliminated. Caranine (with hydroxyl group at C-1), falcatine (with hydroxyl group at C-1, and methoxy group at C-10) and compound 20 (with hydroxyl group at C-1, and a methoxy group at C-2) exhibited an abundant peak at [M-19] + , indicating an intensive loss of water from the [M-1] + ion, leading to an additional double bond that stabilized the fragments [22] .
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Natural Product Communications Vol. 7 (5) , which is 42 mass units higher than that of 20 (m/z 331) confirms that 19 is the acetate of 20. The structure of parkamine has already been established using chemical methods [23] [24] , but there are no structural data available in the literature. However, further isolation and spectroscopic studies of these compounds are necessary for their unambiguous identification and structure determination.
Six Amaryllidaceae alkaloids were identified in the extract of Narcissus poeticus var. recurvus, and two (3, 4) were left unidentified. Considering their low concentrations (<1% of TIC), their isolation and structural elucidation could be problematic. The profile of the alkaloids was dominated by the common alkaloids lycorine (15; 52% of TIC), pancracine (12; 19% of TIC), and galanthine (14; 12% of TIC). In the alkaloid pattern of Sternbergia lutea we identified only two alkaloids, lycorine (15; 95% of TIC) and haemanthamine (11; 5% of TIC). The HuAChE and HuBuChE inhibitory activities of all the alkaloid extracts tested are summarized in Table 2 . The best acetylcholinesterase inhibition activity was shown by the extract of Narcissus poeticus var. recurvus with an IC 50,HuAChE 6.0 ± 0.1 µM. This result can be explained by the high content of galanthamineand lycorine-types of Amaryllidaceae alkaloids (70% of TIC). It is reported that, among the plants of the family Amaryllidaceae, the AChE inhibitory activity is associated mainly with these structural types of alkaloids [25] [26] . Lycorine-type compounds are less active inhibitors than the galanthamine-type and their activity is associated with substitution at positions C-1 and C-2 [25] . Promising HuAChE inhibition activity was also shown by the extracts of N. filifolia and N. filamentosa, with IC 50,HuAChE 18.5 ± 0.8 µM and 21.6 ± 1.1 µM, respectively. Their extracts were dominated by alkaloids of the crinine (N. filamentosa) and homolycorine-type (N. filifolia). So far, the tested crinine-type alkaloids have had only a weak activity against AChE and it appears that the stereochemistry of the 5,10bethanobridge has no effect on the inhibition of AChE activity [27] .
Only five alkaloids of the homolycorine-type have been tested so far, but no acetylcholinesterase inhibitory activity was detected [25, 27] . From this point of view our results are interesting and in contradiction with reported results. In order to recognize the active compound, it seems to be necessary to isolate each of the separate alkaloids and test them in pure form. The other explanation for the various inhibition activities may lie in the use of different types of test enzymes. Acetylcholinesterase from electric eel was used in the previous studies [25, 27] .
There is only limited information about butyrylcholinesterase inhibition activity of extracts and pure alkaloids from Amaryllidaceae species. In comparison with our previous reports [12] [13] [14] [15] , the best HuBuChE activities are demonstrated in the current study by the extracts of S. lutea and N. filamentosa with IC 50, HuBuChE values of 3.7 ± 0.1 µM and 13.0 ± 0.7 µM, respectively Comparable activity was shown also by the extract of Nerine bowdenii [15] , which has a similar alkaloid profile as that of N. filamentosa. Both extracts were dominated by alkaloids of the crinine-type. However, the answer to the question as to which compound/compounds is/are responsible for the butyrylcholinesterase activity may be provided only with the testing of the isolated and identified compound/s. Surprisingly, very good HuBuChE inhibition activity of the extract from Sternbergia lutea was found. We have identified only lycorine and haemanthamine in this extract so far. However, both compounds (isolated in our laboratory from another source) were considered to be inactive (unpublished data). Therefore, the question has to be raised if there is a synergistic activity between the two or more compounds that plays a role in the inhibition activity or if there is a minor so far unidentified structure with a huge potency that inhibits the HuBuChE. The question could be answered after isolation, identification and tests with pure compounds. We hope to achieve this in our following experiments focused on the search for new compounds with HuAChE/HuBuChE inhibition activity from the Amaryllidaceae family. 
Extraction of alkaloids:
Fresh bulbs (3 x 15 g) were extracted 3 times with EtOH (50 mL) at room temperature for 24 h. The solvent was evaporated under reduced pressure and the residue dissolved in 10 mL 2% HCl. After removal of neutral compounds with diethyl ether (3 x 15 mL), the extract was basified with 25% ammonia solution and the alkaloids extracted with EtOAc (3 x 15 mL). The organic solvent was evaporated and 10 mg of each alkaloid extract was used for acetylcholinesterase and butyrylcholinesterase assay. The rest of the dry alkaloid fraction was dissolved in MeOH to a final concentration of 10 mg/mL for further analysis.
GC/MS analysis and identification of alkaloids:
The alkaloid extracts were analyzed using a GCMS-QP2010 plus system (Shimadzu, Japan). An injection of 1 µL of alkaloid solution (1 mg/mL) was introduced in split mode (split ration 1:5) at 270°C. The separation was carried out on a HP-5MS UI column (30 m × 0.25 mm × 0.25 μm, Agilent Technologies Santa Clara, CA, USA). A temperature program from 150°C, ramped at 3°C/min to 300°C and held for 15 min, was used for the separation. The detection range was m/z 35-600, and the detector temperature 200°C. The flow-rate of the carrier gas (helium) was 3 mL/min. The individual alkaloids were identified based on the comparison of their MS with those in the NIST library, with reported spectra in the literature, and finally with spectra of reference compounds isolated earlier in our laboratory (galanthamine, haemanthamine, tazettine, lycorine, ambelline).
Preparation of red blood cell ghosts:
Ghosts were prepared from freshly withdrawn blood (taken from healthy volunteers) according to the method of Steck and Kant [28] , with slight modification. One mL of sodium citrate solution (3.8%, Hoechst Biotika, Slovakia) was added to 10 mL of blood. Then the plasma (HuBuChE) was obtained by centrifugation at 4000 rpm in a Boeco U-32R centrifuge with a Hettich 1611 rotor. Red blood cells were transferred into 50 mL tubes and washed 3 times with 5 mM phosphate buffer (pH 7.4; 5 mL buffer/1 mL of erythrocytes) containing 150 mM sodium chloride (12,000 rpm, Avanti J-30I, rotor JA-30.50). The washed erythrocytes were stirred with 5 mM phosphate buffer (pH 7.4) for 10 mins to ensure lysis. The lysed cells were centrifuged at 20,000 rpm for 10 min. Finally the ghosts (HuAChE) were washed 3 times with phosphate buffer.
Acetylcholinesterase and butyrylcholinesterase assay:
HuAChE and HuBuChE activities were determined using a modified method of Ellman et al. [29] at concentrations of 0.5, 2.5, 5, 12.5, 25, 50, 125, 250 and 500 μg/mL, using acetylthiocholine iodide (ATChI) and butyrylthiocholine iodide (BuTChI) as substrates, respectively. Briefly, 8-15 μL of either ghosts or plasma, 215 μL of 5,5´-dithiobis-2-nitrobenzoic acid (DTNB) and 8 μL of either the sample or appropriate solvent, as a blank sample, were added to the microplate. The reaction was initiated by addition of either ATChI or BuTChI. The final proportion of DTNB to substrate was 1:1. The increase in absorbance at 436 nm (∆A) was measured for 1 min using a Synergy TM HT Multi-Detection Microplate Reader (BioTek, USA). Each measurement was repeated 3 times. Galanthamine, huperzine A and eserine were used as positive standards. The percentage of inhibition (%I) was calculated according to the formula: %I = 100-(∆A BL /∆A SA )*100, where ∆A BL is the increase in absorbance of the blank sample and ∆A SA is the increase in absorbance of the measured sample.
Statistical analysis:
The IC 50 values were calculated with the use of GraphPad Prism 5.02 software.
